Martin Currie Ltd. Acquires 1,139 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Martin Currie Ltd. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,228 shares of the medical equipment provider’s stock after purchasing an additional 1,139 shares during the quarter. Martin Currie Ltd.’s holdings in Intuitive Surgical were worth $1,685,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $30,000. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $31,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

ISRG opened at $491.84 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $175.18 billion, a P/E ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43. The company’s 50-day moving average is $556.28 and its 200 day moving average is $532.68.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.